Healthcare & Life Sciences
Agensys
United States
acquiredacquired
acquired
Stage
About
Agensys was a biotechnology company focused on developing monoclonal antibody therapeutics for oncology. It was acquired by Astellas in 2007 for up to $537 million.
Explore Agensys's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.